Bipolar Flashcards
1
Q
Bipolar Depression (old name: Manic depression)
A
- Occurs in about 1% of the adult population
- Symptoms typically develop in late adolescence/early adulthood
- Women show an increased incidence over men (around 20%)
- Shows strong genetic component
- Characterised by dramatic mood swings, from overtly “high” to the “low” of very sad or hopeless
2
Q
Diagnosis
A
- Defined in the Diagnosis and statistical manual for mental disorders DSM-IV
- It can be difficult since patients often enjoy the manic or hypomanic episodes so may only visit GP when depressed, also symptoms can be confused with anxiety or schizophrenia
- A questionnaire may be used by the doctor if mania suspected. These may include questions like-
- Have you ever found yourself to be abnormally talkative and speaking-very quickly?
- Have you been so manic that people thought you were not yourself
3
Q
Symptoms of a ‘high’ (mania)
A
- Overly good, euphoric mood
- Increased energy, activity and restlessness
- Racing thoughts, talking fast, jumping from one idea to the next
- Provocative, intrusive or aggressive behaviour
- Needs little sleep
- Unrealistic beliefs in one’s abilities and powers
- Increased sexual drive
- Abuse of drugs, particularly cocaine, alcohol and sleeping medications
- A denial that anything is wrong
4
Q
A bipolar range of mood from depression to mania
A
5
Q
Cycling
A
- Mania (peak)
- Depression (bottom)
- Normality (middle)
- 4 episodes over 12 months are known as rapid cycling
- Some patients have multiple episodes with a single week or even day
6
Q
Cycling of mania and depression
A
- Bipolar I disorder- recurrent episodes of mania and possibly depression
- Bipolar II disorder- Recurrent episodes of hypomania and depression
- Can NOT giving antidepressants
- The graph will mood upwards with a greater period of time being spent in mania
- We try to dampen the graph so the oscillations will stay around the normal mood line
7
Q
Dont give antidepressents
A
- If left untreated Bipolar will deteriorate into a worse and worse condition
8
Q
Clinical Intervention in mania
A
- There are two principle aims in the treatment of bipolar disorder
- Short term control of acute maina
- Long term (prophylactic) treatment to maximise the time interval between episodes
9
Q
Treatment of acute mania
A
- Over mania is controlled with neuroleptic Olanzepine (nb atypical anti-psychotics not only block D2 receptors but also 5-HT2A receptors)
-
Valporate but remember restrictions in women of childbearing age. Carbamezapine can be used but note the greater risk of cardiotoxicity and increased propensity for drug interactions
- Blocking excitability
- nb the therapeutic benefit of mood stabilisers is delayed
- If sedation is a priority a BZ such as lorazepam can be administered
10
Q
Mood stablising drugs
A
- Lithium carbonate most commonly used as prophylactic to control mania as well as depression
- Recent use as prophylactic or in acute phase has increased as they have better side-effect and safety profile
- Has to build up for 6 months or more
11
Q
Li- MOA
We don’t actually no
A
- Mood
- Decrease in: Mania; Depression; Mood stabilisation; Suicidality
- Cognition
- Altered cognitive function
- Structure
- Neuroprotective: Increase global grey matter vol; Amygdala, hippocampus, PFC
- Neurotransmission- Increased GABA: Decreased excitatory transmission
- Cellular and intracellular changes: 2nd messenger (PKC, Ionositol, AC; increased anti-oxidant; Neuroprotective
12
Q
Patient care
A
- An important aspect is the teaching of patients to recognise the early symptoms of manic relapse
- Compliance with the lithium treatment is particularly important
- Monitoring of lithium blood concentrations after 1 week and then every 3 months
13
Q
Lithium PK
A
- Lithium is rapidly absorbed from the GI tract
- Li has an elimination half lifeof 24 hr
- Steady state levels are thus not obtained until about day 5
- Li dose must be titrated carefully to obtain blood levels between 0.5-1.2 mmol/L
- Severe toxicity occurs above 2 mmol/L
14
Q
Side effects of Li
A
- Approximately 30% of patients can not tolerate the ADR
- Therapeutic plasma levels of Li are associated with
- GI discomfort and nausea
- Neurological symptoms (which may dissipate) such as fatigue, malaise, muscle weakness
- Decreased water reabsorption by the kidney
- Weight gain. This is a frequent cause of non-compliance
15
Q
Li- Long half-life but narrow therapeutic window
Moderate
A
- Moderate (1.5-2.0 mmol/L
- GI
- Vomiting
- Abdominal pain
- Dry mouth
- Neurological
- Ataxia
- Dizziness
- Slurred speech
- Lethargy or excitement
- Muscle weakness
- GI